Science
Mechanism of Action
The precise mechanism of action for OCTAPEPTIDE-33 on skin has not been elucidated or detailed in the available research data.
Research
Clinical Evidence
Low confidenceN/A
Transparency
Dusting Analysis
Given the absence of identified clinical studies or specific efficacy data, it is not possible to assess if OCTAPEPTIDE-33 is commonly used at ineffective concentrations or represents a 'dusting' ingredient. Its inclusion without clear functional benefits would be questionable.
The Formula
Formulation
Stability
Peptides, including OCTAPEPTIDE-33, exhibit reduced stability when in solution compared to their lyophilized (freeze-dried) form. Solution stability is contingent upon the solvent type, pH, and the specific amino acid sequence. Peptides containing amino acids such as Asparagine (Asn), Glutamine (Gln), Cysteine (Cys), Methionine (Met), Tryptophan (Trp), or Tyrosine (Tyr) generally tend to be less stable. To prevent premature hydrolysis, it is recommended that stock solutions be prepared using dry organic solvents. Additionally, aliquoting peptide solutions prior to freezing is advised to mitigate degradation cycles associated with repeated thawing and refreezing.
Safety
Safety Profile
As OCTAPEPTIDE-33 has not undergone review by the Cosmetic Ingredient Review (CIR), comprehensive safety data, including potential sensitization risk, remains unknown. Further research is required for a complete safety profile.
Your Skin
Skin Compatibility
Our Assessment
Verdict
While initial formulation guidance suggests an optimal pH range for stability, the current research lacks sufficient data regarding OCTAPEPTIDE-33's specific mechanism of action, clinical efficacy, and comprehensive safety profile, preventing a definitive assessment of its value in skincare.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources